Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Moving about.

Literature DB >> 15752370

Moving about.

J K Aronson.

Abstract

Mesh：

Year: 2005 PMID： 15752370 PMCID： PMC1884795 DOI： 10.1111/j.1365-2125.2005.02399.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

15 in total

1. STUDIES ON DIGITALIS IN AMBULATORY CARDIAC PATIENTS: II. The Elimination of Digitalis in Man.

Authors: H Gold; A C Degraff
Journal: J Clin Invest Date: 1929-02 Impact factor: 14.808

2. Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.

Authors: C Csajka; C A Haller; N L Benowitz; D Verotta
Journal: Br J Clin Pharmacol Date: 2005-03 Impact factor: 4.335

3. Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis.

Authors: H J M van Kan; G J Groeneveld; S Kalmijn; M Spieksma; L H van den Berg; H J Guchelaar
Journal: Br J Clin Pharmacol Date: 2005-03 Impact factor: 4.335

4. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.

Authors: Andrew Owen; Chris Goldring; Paul Morgan; David Chadwick; B Kevin Park; Munir Pirmohamed
Journal: Br J Clin Pharmacol Date: 2005-03 Impact factor: 4.335

5. Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.

Authors: Masato Saito; Norio Yasui-Furukori; Tsukasa Uno; Takenori Takahata; Kazunobu Sugawara; Akihiro Munakata; Tomonori Tateishi
Journal: Br J Clin Pharmacol Date: 2005-03 Impact factor: 4.335

6. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.

Authors: P Chaikin; M S Gillen; M Malik; H Pentikis; G R Rhodes; D J Roberts
Journal: Br J Clin Pharmacol Date: 2005-03 Impact factor: 4.335

Moving about.

1. STUDIES ON DIGITALIS IN AMBULATORY CARDIAC PATIENTS: II. The Elimination of Digitalis in Man.

2. Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.

3. Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis.

4. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.

5. Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.

6. Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.

7. Pharmacokinetics of pitavastatin in subjects with Child-Pugh A and B cirrhosis.

8. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.

9. Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes.

10. The pharmacokinetics of halothane (fluothane) anaesthesia.

1. Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.